Abstract
Boceprevir drug is a ketoamide serine protease inhibitor with a linear peptidomimetic structure that exhibits inhibition activity against 2019-nCoV main protease. This paper reports electronic properties of boceprevir and its molecular docking as well as molecular dynamics simulation analysis with protein receptor. For this, the equilibrium structure of boceprevir has been obtained by DFT at B3LYP and ωB97XD levels with 6-311+G(d,p) basis set in gas and water mediums. HOMO–LUMO and absorption spectrum analysis have been used to evaluate the boceprevir’s toxicity and photosensitivity, respectively. Molecular docking simulation has been performed to test the binding affinity of boceprevir with 2019-nCoV MPRO; which rendered a variety of desirable binding locations between the ligand and target protein’s residue positions. The optimum binding location has been considered for molecular dynamics simulation. The findings have been addressed to clarify the boceprevir drug efficacy against the 2019-nCoV MPRO.
Acknowledgements
Authors are grateful to Prof. S. N. Tiwari, Department of Physics, D.D.U. Gorakhpur University, Gorakhpur, for his insightful comments and helpful discussion. D. Sharma expresses gratitude to UGC, New Delhi, India for financial support in the form of the Start-Up Project [F.30-505/2020(BSR)].
-
Research ethics: No human or animal participation in this work.
-
Author contributions: G.T. performed the DFT and molecular docking calculation, helped in formal analysis, wrote the first draft of the manuscript; M.S.C. developed the idea, formal analysis, and performed the MD simulation; D.S. developed the idea, formal analysis, wrote the first draft of the manuscript, carefully examined the results, discussion and final proof of the text. The final version of the manuscript was reviewed, assembled and approved by all of the authors.
-
Competing interests: All authors declared that there is no conflict of interest.
-
Research funding: No funding was received for this research.
-
Data availability: Data will be available/provided on a reasonable request.
References
1. Fu, L, Ye, F, Feng, Y, Yu, F, Wang, Q, Wu, Y, et al.. Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease. Nat Commun 2020;11:4417. https://doi.org/10.1038/s41467-020-18233-x.Suche in Google Scholar PubMed PubMed Central
2. Zhou, P, Yang, XL, Wang, XG, Hu, B, Zhang, L, Zhang, W, et al.. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270–3. https://doi.org/10.1038/s41586-020-2012-7.Suche in Google Scholar PubMed PubMed Central
3. Gorbalenya, AE, Baker, SC, Baric, RS, de Groot, RJ, Drosten, C, Gulyaeva, AA, et al.. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536. https://doi.org/10.1038/s41564-020-0695-z.Suche in Google Scholar PubMed PubMed Central
4. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it.Suche in Google Scholar
5. Phan, LT, Nguyen, TV, Luong, QC, Nguyen, TV, Nguyen, HT, Le, HQ, et al.. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med 2020;382:872–4. https://doi.org/10.1056/nejmc2001272.Suche in Google Scholar
6. Guan, W, Ni, Z, Hu, Y, Liang, W, Ou, C, He, J, et al.. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–20. https://doi.org/10.1056/nejmoa2002032.Suche in Google Scholar PubMed PubMed Central
7. Zhou, F, Yu, T, Du, R, Fan, G, Liu, Y, Liu, Z, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62. https://doi.org/10.1016/s0140-6736(20)30566-3.Suche in Google Scholar PubMed PubMed Central
8. Zhang, L, Lin, D, Sun, X, Curth, U, Drosten, C, Sauerhering, L, et al.. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a-ketoamide inhibitors. Science 2020;368:409–12. https://doi.org/10.1126/science.abb3405.Suche in Google Scholar PubMed PubMed Central
9. Chen, YW, Yiu, CPB, Wong, KY. Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CLpro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Research 2020;9:129. https://doi.org/10.12688/f1000research.22457.2.Suche in Google Scholar PubMed PubMed Central
10. ang, H, Xie, W, Xue, X, Yang, K, Ma, J, Liang, W, et al.. Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol 2005;3:e324. https://doi.org/10.1371/journal.pbio.0030324.Suche in Google Scholar PubMed PubMed Central
11. Dyall, J, Gross, R, Kindrachuk, J, Johnson, RF, Olinger, GG, Hensley, LE, et al.. Middle East respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies. Drugs 2017;77:1935–66. https://doi.org/10.1007/s40265-017-0830-1.Suche in Google Scholar PubMed PubMed Central
12. Ullrich, S, Nitsche, C. The SARS-CoV-2 main protease as drug target. Bioorg Med Chem Lett 2020;30:127377. https://doi.org/10.1016/j.bmcl.2020.127377.Suche in Google Scholar PubMed PubMed Central
13. Rudmann, DG. On-target and off-target-based toxicologic effects. Toxicol Pathol 2013;41:310–14. https://doi.org/10.1177/0192623312464311.Suche in Google Scholar PubMed
14. Strömich, L, Wu, N, Barahona, M, Yaliraki, SN. Allosteric hotspots in the main protease of SARS-CoV-2. J Mol Biol 2022;434:167748. https://doi.org/10.1016/j.jmb.2022.167748.Suche in Google Scholar PubMed PubMed Central
15. Sultana, J, Crisafulli, S, Gabbay, F, Lynn, E, Shakir, S, Trifirò, G. Challenges for drug repurposing in the COVID-19 pandemic era. Front Pharmacol 2020;11:1657. https://doi.org/10.3389/fphar.2020.588654.Suche in Google Scholar PubMed PubMed Central
16. Rane, JS, Pandey, P, Chatterjee, A, Khan, R, Kumar, A, Prakash, A, et al.. Targeting virus–host interaction by novel pyrimidine derivative: an in silico approach towards discovery of potential drug against COVID-19. J Biomol Struct Dyn 2021;39:5768–78. https://doi.org/10.1080/07391102.2020.1794969.Suche in Google Scholar PubMed PubMed Central
17. Chaudhary, RG, Chouke, PB, Bagade, RD, Potbhare, AK, Dadure, KM. Molecular docking and antioxidant activity of Cleome simplicifolia assisted synthesis of cerium oxide nanoparticles. Mater Today Proc 2020;29:1085–90. https://doi.org/10.1016/j.matpr.2020.05.062.Suche in Google Scholar
18. Chouke, PB, Potbhare, AK, Meshram, NP, Rai, MM, Dadure, KM, Chaudhary, K, et al.. Bioinspired NiO nanospheres: exploring in vitro toxicity using Bm-17 and L. rohita liver cells, DNA degradation, docking, and proposed vacuolization mechanism. ACS Omega 2022;7:6869–84. https://doi.org/10.1021/acsomega.1c06544.Suche in Google Scholar PubMed PubMed Central
19. Potbhare, AK, Umekar, MS, Chouke, PB, Bagade, MB, Tarik Aziz, S, Abdala, AA, et al.. Bioinspired graphene-based silver nanoparticles: fabrication, characterization and antibacterial activity. Mater Today Proc 2020;29:720–5. https://doi.org/10.1016/j.matpr.2020.04.212.Suche in Google Scholar
20. Burke, LA, Marks, KM. Drugs to treat viral hepatitis. In: Cohen, J, Powderly, WG, Opal, SM, editors. Infectious diseases. Elsevier; 2017, vol 2:1327–32.e1 pp.10.1016/B978-0-7020-6285-8.00155-6Suche in Google Scholar
21. Becke, AD. Density-functional exchange-energy approximation with correct asymptotic behavior. Phys Rev A 1988;38:3098–100. https://doi.org/10.1103/physreva.38.3098.Suche in Google Scholar PubMed
22. Lee, C, Yang, W, Parr, RG. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B 1988;37:785–9. https://doi.org/10.1103/physrevb.37.785.Suche in Google Scholar PubMed
23. Chai, J-D, Head-Gordon, M. Long-range corrected hybrid density functionals with damped atom–atom dispersion corrections. Phys Chem Chem Phys 2008;10:6615–20. https://doi.org/10.1039/b810189b.Suche in Google Scholar PubMed
24. Sharma, D, Srivastava, AK, Tiwari, SN. In-silico investigation of optical, thermal and electronic properties for 4-n-alkoxy benzoic acid series (nOBA; n = 1–8). J Mol Liq 2019;294:111672. https://doi.org/10.1016/j.molliq.2019.111672.Suche in Google Scholar
25. Tiwari, G, Sharma, D, Dwivedi, KK, Dwivedi, MK. Electronic structure of an anticancer drug DC81 and its interaction with DNA base pairs. AIP Conf Proc 2016;1728:020206.10.1063/1.4946257Suche in Google Scholar
26. Tiwari, A, Bansal, G, Mukhopadhyay, SJ, Bhattacharjee, A, Kanungo, S. Quantum capacitance engineering in boron and carbon modified monolayer phosphorene electrodes for supercapacitor application: a theoretical approach using ab-initio calculation. J Energy Storage 2023;73:109040. https://doi.org/10.1016/j.est.2023.109040.Suche in Google Scholar
27. Tiwari, A, Palepu, J, Choudhury, A, Bhattacharya, S, Kanungo, S. Theoretical analysis of the NH3, NO, and NO2 adsorption on boron-nitrogen and boron-phosphorous co-doped monolayer graphene – a comparative study. FlatChem 2022;34:100392. https://doi.org/10.1016/j.flatc.2022.100392.Suche in Google Scholar
28. Tiwari, A, Chauhan, MS, Sharma, D. Fluorination of 2,5-diphenyl-1,3,4-oxadiazole enhances the electron transport properties for OLED devices: a DFT analysis. Phase Transit 2022;95:888–900. https://doi.org/10.1080/01411594.2022.2129051.Suche in Google Scholar
29. Frisch, MJ, Trucks, GW, Schlegel, HB, Scuseria, GE, Robb, MA, Cheeseman, JR, et al.. Gaussian 16, revision B.01. Wallingford CT: Gaussian, Inc.; 2016.Suche in Google Scholar
30. Dennington, R, Keith, TA, Millam, JM. GaussView, version 6. Shawnee Mission, KS: Semichem Inc.; 2016.Suche in Google Scholar
31. Tiwari, A, Apte, AA, Dyavadi, SK, Balaji, ESK, Bahadursha, N, Kanungo, S. Surface engineered phosphorene using boron and arsenic doping/Co-doping for Co-optimizing the adsorption stability, transduction, and recovery of CO, NO, and SO gases – a density functional theory perspective. Mater Today Commun 2023;36:106627. https://doi.org/10.1016/j.mtcomm.2023.106627.Suche in Google Scholar
32. Tiwari, A, Fernandes, RS, Dey, N, Kanungo, S. Site-specific ammonia adsorption and transduction on a naphthalimide derivative molecule – a complementary analysis involving ab initio calculation and experimental verification. Phys Chem Chem Phys 2023;25:17021–33. https://doi.org/10.1039/d3cp01373a.Suche in Google Scholar PubMed
33. Kumar, S, Tiwari, G, Chauhan, MS, Sharma, D. First principles study of nonlinear optical, electronic properties and absorption spectra of some anti-HIV drugs: a comparative approach. Opt Quant Electron 2023;55:1236. https://doi.org/10.1007/s11082-023-05497-y.Suche in Google Scholar
34. Tiwari, G, Kumar, S, Chauhan, MS, Sharma, D. Ab-initio, molecular docking and md simulation of an anti-hiv drug(lamivudine): an in-silico approach. Biomed Mater Devices 2023. https://doi.org/10.1007/s44174-023-00131-7.Suche in Google Scholar
35. Grosdidier, A, Zoete, V, Michielin, O. SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res 2011;39:W270–7. https://doi.org/10.1093/nar/gkr366.Suche in Google Scholar PubMed PubMed Central
36. Pettersen, EF, Goddard, TD, Huang, CC, Couch, GS, Greenblatt, DM, Meng, EC, et al.. UCSF Chimera – a visualization system for exploratory research and analysis. J Comput Chem 2004;25:1605–12. https://doi.org/10.1002/jcc.20084.Suche in Google Scholar PubMed
37. Phillips, JC, Hardy, DJ, Maia, JDC, Stone, JE, Ribeiro, JV, Bernardi, RC, et al.. Scalable molecular dynamics on CPU and GPU architectures with NAMD. J Chem Phys 2020;153:044130. https://doi.org/10.1063/5.0014475.Suche in Google Scholar PubMed PubMed Central
38. Vanommeslaeghe, K, Hatcher, E, Acharya, C, Kundu, S, Zhong, S, Shim, J, et al.. CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J Comput Chem 2010;31:671–90. https://doi.org/10.1002/jcc.21367.Suche in Google Scholar PubMed PubMed Central
39. Humphrey, W, Dalke, A, Schulten, K. VMD: visual molecular dynamics. J Mol Graph 1996;14:33–8. https://doi.org/10.1016/0263-7855(96)00018-5.Suche in Google Scholar PubMed
40. Wang, E, Fu, W, Jiang, D, Sun, H, Wang, J, Zhang, X, et al.. VAD-MM/GBSA: a variable atomic dielectric MM/GBSA model for improved accuracy in protein-ligand binding free energy calculations. J Chem Inf Model 2021;61:2844–56. https://doi.org/10.1021/acs.jcim.1c00091.Suche in Google Scholar PubMed
41. Forrest, J, Bazylewski, P, Bauer, R, Hong, S, Kim, CY, Giesy, JP, et al.. A comprehensive model for chemical bioavailability and toxicity of organic chemicals based on first principles. Front Mar Sci 2014;1:31. https://doi.org/10.3389/fmars.2014.00031.Suche in Google Scholar
42. Kaschula, CH, Egan, TJ, Hunter, R, Basilico, N, Parapini, S, Taramelli, D, et al.. Structure – activity relationships in 4-aminoquinoline antiplasmodials. The role of the group at the 7-position. J Med Chem 2002;45:3531–9. https://doi.org/10.1021/jm020858u.Suche in Google Scholar PubMed
43. Tiwari, G, Kumar, A, Dwivedi, KK, Sharma, D. In silico investigation of electronic structure, binding patterns and molecular docking of nevirapine: an anti-HIV type-1 drug. Polycycl Aromat Comp 2022;42:2789–804. https://doi.org/10.1080/10406638.2020.1852268.Suche in Google Scholar
44. Tiwari, G, Chauhan, MS, Sharma, D. Systematic in silico studies of corticosteroids and its binding affinities with glucocorticoid receptor for covid-19 treatment: ab-initio, molecular docking and MD simulation studies. Polycycl Aromat Comp 2023;43:4654–69. https://doi.org/10.1080/10406638.2022.2092878.Suche in Google Scholar
45. Kowalska, J, Rok, J, Rzepka, Z, Wrześniok, D. Drug-induced photosensitivity – from light and chemistry to biological reactions and clinical symptoms. Pharmaceuticals 2021;14:723. https://doi.org/10.3390/ph14080723.Suche in Google Scholar PubMed PubMed Central
46. Gould, JW, Mercurio, MG, Elmets, CA. Cutaneous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol 1995;33:551–73. https://doi.org/10.1016/0190-9622(95)91271-1.Suche in Google Scholar PubMed
47. Reddy, PG, Kumar, VK, Raju, VA, Ram, JR, Rraju, NA. Novel spectrophotometric method development for the estimation of boceprevir in bulk and in pharmaceutical formulations. Res J Pharm Technol 2017;10:4313. https://doi.org/10.5958/0974-360x.2017.00789.2.Suche in Google Scholar
48. Laskowski, RA, et al.. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993;26:283–91. https://doi.org/10.1107/S0021889892009944.Suche in Google Scholar
49. Yadav, R, Imran, M, Dhamija, P, Chaurasia, DK, Handu, S. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2. J Biomol Struct Dyn 2020;39:6617–32. https://doi.org/10.1080/07391102.2020.1796812.Suche in Google Scholar PubMed PubMed Central
50. McConkey, B, Sobolev, V, Edelman, M. The performance of current methods in ligand-protein docking. Curr Sci 2002;83:845–55.Suche in Google Scholar
51. Tiwari, G, Chauhan, MS, Sharma, D. Estimation of binding sites of efavirenz with 3EO9 receptor: in silico molecular docking and molecular dynamics studies. Polycycl Aromat Comp 2022;42:7256–66. https://doi.org/10.1080/10406638.2021.1998148.Suche in Google Scholar
52. Thakral, S, Narang, R, Kumar, M, Singh, V. Synthesis, molecular docking and molecular dynamic simulation studies of 2-chloro-5-[(4-chlorophenyl)sulfamoyl]-N-(alkyl/aryl)-4-nitrobenzamide derivatives as antidiabetic agents. BMC Chem 2020;14:49. https://doi.org/10.1186/s13065-020-00703-4.Suche in Google Scholar PubMed PubMed Central
53. Mena-Ulecia, K, Tiznado, W, Caballero, J. Study of the differential activity of thrombin inhibitors using docking, QSAR, molecular dynamics, and MM-GBSA. PLoS One 2015;10:e0142774. https://doi.org/10.1371/journal.pone.0142774.Suche in Google Scholar PubMed PubMed Central
54. Gilis, D, Rooman, M. Stability changes upon mutation of solvent-accessible residues in proteins evaluated by database-derived potentials. J Mol Biol 1996;257:1112–26. https://doi.org/10.1006/jmbi.1996.0226.Suche in Google Scholar PubMed
© 2023 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Research Articles
- In silico study of inhibition activity of boceprevir drug against 2019-nCoV main protease
- Analysis of the SARS-CoV-2 nsp12 P323L/A529V mutations: coeffect in the transiently peaking lineage C.36.3 on protein structure and response to treatment in Egyptian records
- In vitro antimicrobial and antioxidant activities, essential oil composition, and in silico molecular modeling analysis of secondary metabolites from roots of Verbascum sinaiticum
- Synthesis and antitumor activity of model cyclopentene-[g]annelated isoindigos
Artikel in diesem Heft
- Frontmatter
- Research Articles
- In silico study of inhibition activity of boceprevir drug against 2019-nCoV main protease
- Analysis of the SARS-CoV-2 nsp12 P323L/A529V mutations: coeffect in the transiently peaking lineage C.36.3 on protein structure and response to treatment in Egyptian records
- In vitro antimicrobial and antioxidant activities, essential oil composition, and in silico molecular modeling analysis of secondary metabolites from roots of Verbascum sinaiticum
- Synthesis and antitumor activity of model cyclopentene-[g]annelated isoindigos